Crombie REIT Announces Monthly Distribution for Investors
Crombie REIT Announces Monthly Distribution
Crombie Real Estate Investment Trust (CRR) has disclosed its latest monthly distribution, focusing on supporting its Unitholders. This generous move reflects Crombie's commitment to providing consistent returns while enriching communities it serves.
Details of the October Distribution
The announced distribution stands at $0.07417 per unit, set for the period spanning from October 1 to October 31 of the year. This approach not only benefits the current Unitholders but also showcases Crombie's ongoing dedication to maintaining fruitful investment avenues.
Payment Schedule
For those invested in Crombie REIT, this distribution will be payable on November 15. Unitholders will be recorded as of October 31, ensuring that they benefit from this distribution.
About Crombie REIT
This real estate investment trust has a clear vision centered on enriching communities by creating spaces that foster growth and sustainability. Crombie focuses on quality real estate assets in grocery-anchored retail, retail-related industrial, and mixed-use residential properties.
Portfolio Overview
By the close of June 2024, Crombie's impressive portfolio spanned a whopping 304 properties, totaling approximately 19.3 million square feet. This includes not only owned assets but also significant joint ventures, which contribute to a diversified growth approach.
Future Development Projects
Looking ahead, Crombie REIT is actively engaged in developing future projects that promise to further enhance its portfolio and community impact. These initiatives are a testament to its commitment to fostering community growth while ensuring profitability for shareholders.
Why Invest in Crombie REIT (CRR)?
Investing in Crombie REIT not only promises stability due to its consistent distributions but also highlights its innovative approach to real estate. The emphasis on community and sustainability makes it an attractive option for responsible investors.
Frequently Asked Questions
What is the distribution payout for October 2024?
The distribution payout is set at $0.07417 per unit for the month of October 2024.
When will the distribution be paid?
The distribution will be paid on November 15, 2024, to Unitholders recorded as of October 31, 2024.
What types of properties does Crombie REIT invest in?
Crombie invests in grocery-anchored retail, retail-related industrial, and mixed-use residential properties.
How many properties are included in Crombie's portfolio?
Crombie's portfolio encompasses 304 properties, totaling approximately 19.3 million square feet as of June 30, 2024.
What makes Crombie REIT a good investment choice?
Crombie REIT offers consistent distributions and focuses on enriching communities, providing an attractive investment opportunity.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- ManpowerGroup Prepares for Earnings Release with Anticipation
- Petfinder and Purina Join Forces to Enhance Pet Wellness
- CarSaver Launches Boost+: A Game-Changer for Dealer Profits
- RBC Optimizes Stock Target for Johnson & Johnson Amid Growth
- Polkadot’s sub0 Conference: A Hub for Innovation and Growth
- ASML's Earnings Reveal Market Challenges for Chipmakers Ahead
- Intel and AMD Unite to Reinforce x86 Architecture Against Arm
- Freddie Mac's Strategic Move to Auction Off Non-Performing Loans
- Freddie Mac Completes $13.9 Million Non-Performing Loan Sale
- Florida Realtors Relief Fund Aids Hurricane Recovery Efforts
Recent Articles
- Ladybug Nutratech Reports Impressive Sales Growth in 2024
- European Wax Center Rises in Franchise Times Rankings for 2024
- Exploring the Impact of Semiconductor News on Direxion ETFs
- OneRail's Bill Catania Celebrated as Top Entrepreneur by GS
- WOLFBOX Marks Five Years as a Leader in Automotive Tech
- Nevada King Gold Expands Exploration with Phase 3 Drill Plan
- CTAboi Aims to Simplify Beneficial Ownership Reporting for LLCs
- Progress at Libero Copper's Mocoa Project: Resource Expansion
- Chronograph Partners with Cambridge Associates for Enhanced Insights
- Outcrop Silver Expands Aguilar High-Grade Discoveries
- SOLTECH Achieves Women's Business Enterprise Certification
- REI Systems Lands Major Education Grant with GovGrants® Solution
- Axcelis Technologies Reveals Upcoming Q3 2024 Financial Results
- Blueprint Medicines To Reveal Q3 2024 Financial Insights Soon
- Acurx Pharmaceuticals Schedules Q3 2024 Conference Call
- Hyundai Mobis Expands Electrification with New European Facility
- Subway® Unveils Spicy Ghost Pepper Bread to Ignite Sandwiches
- Aetna Unveils SimplePay Health: Redefining Health Care for Users
- Iris Energy Accelerates Texas Data Center Energization Plans
- Baird Optimizes MasterCard Price Target Amidst Positive Growth
- Indaptus Therapeutics Remains Strong with Buy Rating and Updates
- Exelixis Celebrates Legal Win and Looks Toward Future Growth
- Albertsons Faces Challenges Amid Market Share Decline
- Uxin Joins Forces with Wuhan Economic Zone for Growth
- Morgan Stanley Reports Impressive 32% Increase in Profits
- Cautious Investors Slow Asian Bond Capital Inflows Amidst Uncertainty
- Morgan Stanley Surges on Strong Q3 Earnings Report
- Top High-Yield Stocks to Enhance Your Investment Strategy
- U.S. Bancorp Reports Impressive Earnings Amid Rising Rates
- Challenges Loom for Electric Vehicle Owners Amidst Depreciation
- Worksport Engages Investors in Insightful Chat with Analyst
- Torr Metals Advances Filion Gold Exploration with New Crews
- Text Request and Commify Join Forces to Enhance Messaging Solutions
- Exploring the Rapid Growth of the 3D Printing Medical Devices Market
- Exploring the Growth of the Global Identity Verification Market
- Global Breast Implants Market Growth to Reach $4.46 Billion
- Lee Shavel's New Role: A Vision for the Insurance Industry
- Chefs’ Warehouse to Reveal Third Quarter Financials Soon
- Northern Technologies International Corporation Declares Dividend
- Standard BioTools Prepares for Upcoming Financial Results Call
- Western Metallica Secures C$1 Million to Propel Copper Exploration
- Interfor Corporation Sells Québec Operations to Focus Growth
- Finov8r: Transforming Financial Advisory for Future Growth
- Cross Country Healthcare Celebrates Wellness Recognition by Newsweek
- NEQSOL Holding Expands Global Business through Titanium Acquisition
- Enthusiast Gaming's Record-Breaking Spectacle at Luminosity Event
- Uxin Forms Joint Venture to Expand Used Car Market Strategy
- Exploring Future Beauty Trends: Innovations for 2025 and Beyond
- Jacobs-Joint Venture Wins Major Wastewater Infrastructure Project
- Latigo Biotherapeutics Initiates Phase 1 Trial for LTG-305